Loading
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 07 Jan 2026 for Biohaven Ltd.. Read the official filing
Filing timeline
BuySaleBruce Car
Insider track record
Disclosed buys
1
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+16.4%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
No signal scores available.
Bruce Car: trading record in brief
Bruce Car discloses dealings in 2 companies, chiefly Agios Pharmaceuticals, Inc. and Biohaven Ltd. In total, 6 filings cover trades dated from 6 January 2022 to 5 January 2026.
Every open-market trade on record is a purchase: 1 purchase worth €938k, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 5 option exercises.
Most recently, on 7 January 2026, the filings show an option exercise in Biohaven Ltd. The latest purchase dates back some time: it was published 850 days ago, on 20 June 2024. Typically, a trade is published a median of 4 days after it takes place. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Bruce Car
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
6 of 6 declarations
